SmartCADD: AI-QM Empowered Drug Discovery Platform with Explainability
Journal of Chemical Information and Modeling · 09.09.2024 · 64 (17) · 6799-6813
DOI: 10.1021/acs.jcim.4c00720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 23.08.2024. Verfasst von Ayesh Madushanka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Southern Methodist University, Dallas, Texas 75205, United States. Hauptthemen laut MEDLINE: Drug Discovery, Quantum Theory, Artificial Intelligence. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 116 Literaturangaben. Gefördert von: Division of Chemistry.
Abstract (Originalsprache)
Artificial intelligence (AI) has emerged as a pivotal force in enhancing productivity across various sectors, with its impact being profoundly felt within the pharmaceutical and biotechnology domains. Despite AI's rapid adoption, its integration into scientific research faces resistance due to myriad challenges: the opaqueness of AI models, the intricate nature of their implementation, and the issue of data scarcity. In response to these impediments, we introduce SmartCADD, an innovative, open-source virtual screening platform that combines deep learning, computer-aided drug design (CADD), and quantum mechanics methodologies within a user-friendly Python framework. SmartCADD is engineered to streamline the construction of comprehensive virtual screening workflows that incorporate a variety of formerly independent techniques─spanning ADMET property predictions, de novo 2D and 3D pharmacophore modeling, molecular docking, to the integration of explainable AI mechanisms. This manuscript highlights the foundational principles, key functionalities, and the unique integrative approach of SmartCADD. Furthermore, we demonstrate its efficacy through a case study focused on the identification of promising lead compounds for HIV inhibition. By democratizing access to advanced AI and quantum mechanics tools, SmartCADD stands as a catalyst for progress in pharmaceutical research and development, heralding a new era of innovation and efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Southern Methodist University, Dallas, Texas 75205, United States.
- Department of Computer Science, Southern Methodist University, Dallas, Texas 75205, United States.
ORCID-Profile: Eli Laird, Elfi Kraka
Förderung
- Division of Chemistry
Zitieren
APA
Madushanka, A., Laird, E., Clark, C., & Kraka, E. (2024). SmartCADD: AI-QM Empowered Drug Discovery Platform with Explainability. Journal of Chemical Information and Modeling, 64(17), 6799-6813. https://doi.org/10.1021/acs.jcim.4c00720
Vancouver
Madushanka A, Laird E, Clark C, Kraka E. SmartCADD: AI-QM Empowered Drug Discovery Platform with Explainability. Journal of Chemical Information and Modeling. 2024;64(17):6799-6813. doi:10.1021/acs.jcim.4c00720
BibTeX
@article{Madushanka2024,
author = {Madushanka, Ayesh and Laird, Eli and Clark, Corey and Kraka, Elfi},
title = {SmartCADD: AI-QM Empowered Drug Discovery Platform with Explainability},
journal = {Journal of Chemical Information and Modeling},
year = {2024},
volume = {64},
number = {17},
pages = {6799--6813},
doi = {10.1021/acs.jcim.4c00720}
}
EUVIMED